Dexcom (DXCM) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Dexcom (DXCM) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.86% |
| Mar 31, 2026 | -25.36% |
| Dec 31, 2025 | -5.81% |
| Sep 30, 2025 | 57.84% |
| Jun 30, 2025 | 70.59% |
| Mar 31, 2025 | -30.52% |
| Dec 31, 2024 | 12.70% |
| Sep 30, 2024 | -6.20% |
| Jun 30, 2024 | -1.98% |
| Mar 31, 2024 | -42.88% |
| Dec 31, 2023 | 112.34% |
| Sep 30, 2023 | 4.14% |
| Jun 30, 2023 | 138.48% |
| Mar 31, 2023 | -47.06% |
| Dec 31, 2022 | -9.29% |
| Sep 30, 2022 | 98.82% |
| Jun 30, 2022 | -47.69% |
| Mar 31, 2022 | 1,935.85% |
| Dec 31, 2021 | -106.07% |
| Sep 30, 2021 | 11.35% |